Cambridge Therapeutic Technologies
Teaneck, US · Delaware LLC
Find your way into Cambridge Therapeutic Technologies
15 people in our graph share verified history with the Cambridge Therapeutic Technologies team — schools, employers, funds. One of them is your warm intro.
Michele Battleunlockedknows John Klein · together at Roosevelt University
×11knows the team · via Roosevelt University
Founders & leadership
JK
John KleininChairmanJohn Klein founded Cambridge Therapeutic Technologies in 2011, focusing on pharmaceutical distribution and combination drug therapies globally. Previously, he launched Dava Pharmaceutical Company and held operations roles at Ivax Pharmaceutical, NovaDel Pharma, and Zenith Laboratories, with education including a BS and MBA in finance from Roosevelt University and postgraduate studies in business and finance.
BA
Barry A. PosnerExecutive
JD
Joseph DosSantosExecutive
Board
MW
Marc WassermanBoard director
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2016
▶$6MraisedOct 2016 · 14 investors · PharmaceuticalsRule 506(b)
▶$6MraisedOct 2016 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John KleinExecutive Officer, Director
- Marc WassermanDirector
- Barry A. PosnerExecutive Officer, Director
- Joseph DosSantosExecutive Officer
- Offering amount
- $7M
- Amount sold
- $6M
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cambridge Therapeutic Technologies raised?
- Cambridge Therapeutic Technologies has disclosed $6M raised across 1 round.
- Where is Cambridge Therapeutic Technologies headquartered?
- Cambridge Therapeutic Technologies is headquartered in Teaneck, US.